Physician profile
Bridget Murray Cully
NPI 1356154157
$1,026.07
in general payments reported to CMS, 2019-2025
14 companies · $1,010 in 2025
The $1,010 reported for 2025 was more than what 87% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $16.33 · 2025: $1,010.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,010.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,009.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $263.99 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $116.90 | 2025 | Xifaxan |
| Novo Nordisk INC | $94.49 | 2025 | Rybelsus, Ozempic, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $90.88 | 2025 | Jardiance |
| Pfizer INC. | $86.46 | 2025 | |
| Amgen INC. | $57.10 | 2025 | Otezla, Repatha, Evenity |
| Astrazeneca Pharmaceuticals LP | $56.79 | 2025 | Airsupra, Farxiga |
| Glaxosmithkline, LLC. | $56.10 | 2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Neurocrine Biosciences, INC. | $50.82 | 2025 | |
| Lilly USA, LLC | $35.61 | 2022-2025 | Zepbound |
| Seqirus USA INC | $33.21 | 2025 | Fluad, Flucelvax |
| Renalytix Ai, INC. | $32.13 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Exact Sciences Corporation | $26.18 | 2025 | The Cologuard Plus Collection Kit |
| Astellas Pharma US INC | $25.41 | 2025 | Veozah |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridget Cully listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.